Bone necrosis of the jaws in five patients taking bisphosphonates;Ostéonécrose des maxillaires sous bisphosphonates: Cinq cas

Revue de Stomatologie et de Chirurgie Maxillo-Faciale

Volumn 107, Issue 6, 2006, Pages 417-422

  Woeller, A ^a   Gering, A ^a   Brix, M ^a   Bettega, G ^a   Lebeau, J ^a  

^a HÔPITAL MICHALLON   (France)

Author keywords

Bisphosphonates; Jaws; Osteonecrosis

Indexed keywords

EID: 33845941454     PISSN: 00351768     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-1768(06)77080-2     Document Type: Article

References (12)

1. Ott S. Long-term safety of bisphosphonates. J Clin Endocrinol Metab 2005;90:1897-9.
2. Komatsubara S, Mori S, Mashiba T, Li J, Nonaka K, Kaji Y et al. Suppressed bone turn over by bisphosphonates treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib. J Bone Miner Res 2004;19:999-1005.
3. Santini D, Vincenzi B, Avvisati G, Dicuonzo G, Battistoni F, Gavasci M et al. Pamidronate induces modifications of circulating angiogenetic factors in cancer patients. Clin Cancer Res 2002;8:1080-4.
4. Santini D, Vincenzi B, Dicuonzo G, Avvisati G, Massacesi C, Battistoni F et al. Zoledronic acid induces significant and longlasting modifications of circulating angiogenic factors in cancer patients. Clin Cancer Res 2003;9:2893-7.
5. st century? J Oral Maxillofac Surg 2005;63:682-9.
6. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527-34.
7. Wang J, Goodger NM, Pogrel MA. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 2003;61:1104-7.
8. http://www.vidalcim.net/thalidomide/pharmacodynamie/2005
9. http://www.vidalcim.net/velcade/pharmacodynamie/2005
10. Rosenberg A. Os, articulations et tumeurs des tissus mous. In Cotran, Kumar et Collins, Anatomie pathologique tome 2 ; p. 1453-87. Padoue, Piccin Nuova, 2000.
11. Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Bisphosphonate- associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 2005;104:83-93.
12. Carter G, Goos AN, Doecke C. Bisphosphonates and avascular necrosis of the jaw: a possible association. Med J Aust 2005;182:413-5.